Traders should monitor the SEC review process for the S-4 filing as the next critical milestone for the EMJ merger. The strong performance of the digital asset strategy may support valuation arguments, but execution risk remains until the deal closes.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Apr 17 $7.62entry
- T+1 · 7mo ago −5.51%α −5.31% · $7.20
- T+5 · 7mo ago −5.51%α −6.05% · $7.20
- T+20 · 6mo ago −1.57%α −5.66% · $7.50
- T+60 · 4mo ago −69.69%α −75.83% · $2.31
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
SRx Health Solutions provided an update on its proposed merger with EMJ Crypto Technologies, including operational progress and the filing of a Form S-4 registration statement with the SEC. The company highlighted a $18 million deployment into a digital asset treasury strategy that achieved a 10.67% outperformance versus the S&P 500 in March 2026.
Key Facts
- SRx Health Solutions and EMJ Crypto Technologies issued a joint letter to shareholders updating on the proposed merger.
- The company filed a Form S-4 registration statement with the SEC this week, initiating the regulatory review process.
- EMJ deployed $18 million into a digital asset treasury hedging strategy, achieving a 5.69% return in March 2026 while the S&P 500 declined 4.98%.
- The company acquired shares in Compass Inc. and increased its investment in Opendoor Technologies Inc.
- The merger is expected to close pending SEC approval of the S-4 filing.
Financial Impact
The $18 million digital asset strategy generated a 10.67% outperformance versus the S&P 500 in March 2026, with mid-April gains of 3.5% in hedging pool and 8% in long treasury holdings.
Risk Factors
- Regulatory approval risk for the S-4 filing
- Market volatility in digital assets could impact the performance of the treasury strategy
- Failure to close the merger could result in significant downside
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-017736 |
| Exhibit: ex99-1.htm | 0001493152-26-017736 |
| Document: 0001493152-26-017736-index-headers.html | 0001493152-26-017736 |
| Document: 0001493152-26-017736-index.html | 0001493152-26-017736 |
| Document: 0001493152-26-017736.txt | 0001493152-26-017736 |
Track record
30 reports on SRXH
4 of 6 bullish or bearish reports moved the stock their way by T+5. Best: +77.11% at T+60 after the Jun 18, 2026 report. 4 of 6 went positive at some point.
Filters
- Nov 20, 20261d ago Press Release Neutral 3/10 Entry $0.8402 Now $0.8000 −4.78% settles Nov 30
- Nov 20, 20261d ago SC 13D Neutral 5/10 Entry $0.9950 Now $0.8000 −19.60% settles Nov 30
- Oct 30, 202622d ago Press Release Neutral 3/10 Entry $1.01 to $0.8116 Now $0.8000 −20.79% ▼ −19.64% −16.94% vs SPY
- Oct 7, 20266w ago 8-K Mixed 6/10 Entry $1.49 to $1.29 Now $0.8000 −46.31% ▼ −13.42% −12.44% vs SPY
- Oct 6, 20266w ago 8-K Neutral 4/10 Entry $1.49 to $1.29 Now $0.8000 −46.31% ▼ −13.42% −12.44% vs SPY
- Sep 24, 20268w ago Press Release Neutral 3/10 Entry $1.73 to $1.61 Now $0.8000 −53.76% ▼ −6.94% −6.52% vs SPY
- Sep 9, 202610w ago 8-K Neutral 3/10 Entry $1.51 to $1.60 Now $0.8000 −47.02% ▲ +5.96% +6.62% vs SPY
- Sep 2, 202611w ago 8-K Neutral 5/10 Entry $1.56 to $1.59 Now $0.8000 −48.72% ▲ +1.92% +3.07% vs SPY
- Aug 28, 202612w ago 8-K Bearish 5/10 Entry $1.68 to $1.59 Now $0.8000 +52.38% ▲ +5.65% +5.51% vs SPY
- Aug 19, 202613w ago 8-K Mixed 5/10 Entry $1.87 to $1.84 Now $0.8000 −57.22% ▼ −1.60% −1.22% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers